Sema4 Holdings Corp - Ordinary Shares - Class A Stock News

The top five biotech stocks today have several commonalities. Among them are strong ratings.

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx today announced the commercial expansion into Inborn Errors of Immunity (IEI).

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx today announced inducement grants under Nasdaq Listing Rule 5635(c)(4).

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) announced today they have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025.

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights. Multiscore is embedded into GeneDx's interpretation plat...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions will be presented at the 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting. GeneDx will showcase its leadership in genomic research and innovation, driving the industry forwar...

GeneDx Holdings Corp. is delivering strong revenue growth, but it is still burning cash, which makes me hesitant. At 7x sales, WGS stock feels expensive, given its current financials. If GeneDx can prove it can generate sustainable free cash flow, I'd reconsider my stance.

In a stock market that favors the giants, it's still possible to reap big gains investing in Wall Street's small fries. The post How This Top Small-Cap Growth Fund Wins Big appeared first on Investor's Business Daily.